Tower Research Capital (TRC)’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-76
Closed -$1K 6386
2021
Q2
$1K Buy
+76
New +$943 ﹤0.01% 5319
2020
Q4
Sell
-302
Closed -$4K 5501
2020
Q3
$4K Buy
+302
New +$3.5K ﹤0.01% 4460

Other funds holding AMYT

Tower Research Capital (TRC)'s AMYT Position: Q3 2021 in Review

Tower Research Capital (TRC) sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q3 2021, closing a stake of 76 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in AMYT in Q3 2020 and held it in 2 quarters. The position peaked at $4K in Q3 2020. 65 funds tracked by Wall St. Rank hold AMYT as of Q3 2021.

  • Tower Research Capital (TRC) reported no remaining Amryt Pharma plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 76 Amryt Pharma plc American Depositary Shares shares in Q3 2021, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2020 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Amryt Pharma plc American Depositary Shares position peaked at $4K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q3 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.